228
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Adding two culture-specific ‘bolt-on’ dimensions on the Thai version of EQ-5D-5L: an exploratory study in patients with diabetes

, , & ORCID Icon
Pages 321-329 | Received 02 Jun 2018, Accepted 14 Sep 2018, Published online: 10 Oct 2018

References

  • Brooks R. EuroQol: the current state of play. Health Policy. 1996 Jul;37(1):53–72.
  • Kind P, Brooks R, Rabin R. EQ-5D concepts and methods. Dordrecht: Springer; 2005.
  • Sakthong P. Measurement of clinical-effect: utility. J Med Assoc Thai. 2008 Jun;91(Suppl 2):S43–52.
  • Thavorncharoensap M. Measurement of utility. J Med Assoc Thai. 2014 May;97(Suppl 5):S43–49.
  • National institute for health care excellence. Guide to the methods of technology appraisal 2013 [cite 2014 April 14]. Available from: https://www.nice.org.uk/process/pmg9/chapter/the-reference-case#measuring-and-valuing-health-effects
  • Rowen D, Azzabi Zouraq I, Chevrou-Severac H, et al. International regulations and recommendations for utility data for health technology assessment. Pharmacoeconomics. 2017 Dec;35(Suppl 1):11–19.
  • Rencz F, Gulácsi L, Drummond M, et al. EQ-5D in central and Eastern Europe: 2000–2015. Qual Life Res. 2016 Nov;25(11):2693–2710.
  • Devlin NJ, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy. 2017 Apr;15(2):127–137.
  • Tosh J, Brazier J, Evans P, et al. A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health. 2012 Jan;15(1):118–127.
  • Espallargues M, Czoski-Murray CJ, Bansback NJ, et al. The impact of age-related macular degeneration on health status utility values. Invest. Ophthalmol Vis Sci. 2005 Nov;46(11):4016–4023.
  • Grutters JP, Joore MA, van der Horst F, et al. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints. Qual Life Res. 2007 Oct;16(8):1439–1449.
  • Swinburn P, Lloyd A, Boye KS, et al. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from Psoriasis: lessons learned from a feasibility study in the UK. Value Health. 2013 Dec;16(8):1156–1162.
  • Yang Y, Rowen D, Brazier J, et al. An exploratory study to test the impact on three “bolt-on” items to the EQ-5D. Value Health. 2015 Jan;18(1):52–60.
  • Luo N, Wang X, Ang M, et al. A vision “bolt-on” item could increase the discriminatory power of the EQ-5D index score. Value Health. 2015 Dec;18(8):1037–1042.
  • Perneger TV, Courvoisier DS. Exploration of health dimensions to be included in multi-attribute health-utility assessment. Int J Qual Health Care. 2011 Feb;23(1):52–59.
  • Hoeymans N, van Lindert H, Westert GP. The health status of the Dutch population as assessed by the EQ-6D. Qual Life Res. 2005 Apr;14(3):655–663.
  • Yang Y, Brazier J, Tsuchiya A. Effect of adding a sleep dimension to the EQ-5D descriptive system: a “bolt-on” experiment. Med Decis Making. 2014 Jan;34(1):42–53.
  • WHOQOL Group. The development of the World Health Organization quality of life assessment instrument (the WHOQOL). Quality of life assessment: international perspectives. Springer, Berlin, Heidelberg; 1994.
  • Molzahn AE, Kalfoss M, Schick Makaroff K, et al. Comparing the importance of different aspects of quality of life to older adults across diverse cultures. Age Ageing. 2011 Mar;40(2):192–199.
  • U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006 Oct;4:79.
  • Chassany O, Sagnier P, Marquis P, et al. Patient-reported outcomes; the example of health-related quality of life-a European guidance document for the improved integration of health-related quality of life assessment in drug approval process. DIA J. 2001;36:209–238.
  • Cheung YB, Thumboo J. Developing health-related quality-of-life instruments for use in Asia: the issues. Pharmacoeconomics. 2006;24(7):643–650.
  • Feng Y, Herdman M, van Nooten F, et al. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D. Qual Life Res. 2017 Aug;26(8):2067–2078.
  • Luo N, Wang Y, How CH, et al. Interpretation and use of the 5-level EQ-5D response labels varied with survey language among Asians in Singapore. J Clin Epidemiol. 2015 Oct;68(10):1195–1204.
  • Bailey H, Kind P. Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets. Qual Life Res. 2010 Oct;19(8):1145–1154.
  • Mahlich J, Dilokthornsakul P, Sruamsiri R, et al. Cultural beliefs, utility values, and health technology assessment. Cost Effectiveness and Resource Allocation. 2018;16(1):19.
  • Teerawattananon Y. Thai health technology assessment guideline development. J Med Assoc Thailand. 2011;91(6):11.
  • Walley T, Rawlins M, Stein K. Health technology assessment—the role of the pharmaceutical panel. Br J Clin Pharmacol. 1998 Mar;45(3):217–220.
  • Hampton NZ, Qin-Hilliard DB. Dimensions of quality of life for Chinese adults with spinal cord injury: a qualitative study. Disabil Rehabil. 2004 Feb 18;26(4):203–212.
  • Schwartz SH. Individualism-collectivism: critique and proposed refinements. J Cross Cult Psychol. 1990;21(2):139–157.
  • Kramer EJ, Kwong K, Lee E, et al. Cultural factors influencing the mental health of Asian Americans. West J Med. 2002;176(4):227–231.
  • Zhang W, Ta VM. Social connections, immigration-related factors, and self-rated physical and mental health among Asian Americans. Soc Sci Med. 2009 Jun;68(12):2104–2112.
  • Die AH, Seelbach WC. Problems, sources of assistance, and knowledge of services among elderly Vietnamese immigrants1. Gerontologist. 1988;28(4):448–452.
  • Kim HK, McKenry PC. Social Networks and. Support: A comparison of African Americans, Asian Americans, Caucasians, and Hispanics. J Comp Fam Stud. 1998;29(2):313–334.
  • Rotheram-Borus MJ, Stein JA, Jiraphongsa C, et al. Benefits of family and social relationships for Thai parents living with HIV. Prev Sci. 2010 Sep;11(3):298–307.
  • Hewes GW. The anthropology of posture. Scientific American. 1957;196(2):122–133.
  • Benfayed R, Hamilton D, Moran M, et al. Interpretation of kneeling. Orthop Muscular Syst. 2017;06:240.
  • Xie F, Li S-C, Fong K-Y, et al. What health domains and items are important to patients with knee osteoarthritis? A focus group study in a multiethnic urban Asian population. Osteoarthritis Cartilage. 2006 Mar;14(3):224–230.
  • Yaghmaie F. Content validity and its estimation. J Med Educ. 2003;3(1):25–27.
  • Pattanaphesaj J, Thavorncharoensap M, Ramos-Goñi JM, et al. The EQ-5D-5L valuation study in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):551–558.
  • Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health. 2006 Oct;29(5):489–497.
  • Ferketich S. Focus on psychometrics. Aspects of item analysis. Res Nurs Health. 1991 Apr;14(2):165–168.
  • Aletras VH, Kostarelis A, Tsitouridou M, et al. Development and preliminary validation of a questionnaire to measure satisfaction with home care in Greece: an exploratory factor analysis of polychoric correlations. BMC Health Serv Res. 2010;10:189.
  • Kim SH, Hwang JS, Kim TW, et al. Validity and reliability of the EQ-5D for cancer patients in Korea. Support Care Cancer. 2012 Dec;20(12):3155–3160.
  • Kim TH, Jo MW, Lee SI, et al. Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res. 2013 Oct;22(8):2245–2253.
  • Hunger M, Sabariego C, Stollenwerk B, et al. Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual Life Res. 2012 Sep;21(7):1205–1216.
  • Holmes J, McGill S, Kind P, et al. Health-related quality of life in type 2 diabetes (TARDIS-2). Value Health. 2000 Nov-Dec;3(Suppl 1):47–51.
  • Wexler DJ, Grant RW, Wittenberg E, et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006 Jul;49(7):1489–1497.
  • Pattanaphesaj J, Thavorncharoensap M. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health Qual Life Outcomes. 2015 Feb;13:14.
  • Koh D, Abdullah AM, Wang P, et al. Validation of Brunei’s Malay EQ-5D questionnaire in patients with type 2 diabetes. PLoS One. 2016;Nov;11(11):e0165555.
  • Mulhern B, Meadows K. The construct validity and responsiveness of the EQ-5D, SF-6D and diabetes health profile-18 in type 2 diabetes. Health Qual Life Outcomes. 2014 Mar;12:42.
  • Sakthong P, Sonsa-Ardjit N, Sukarnjanaset P, et al. Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases. Qual Life Res. 2015 Dec;24(12):3015–3022.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.